Others

Outcome of Board Meeting - Sale of Trade Marks of Oncology Marketing Division

| Updated on November 27, 2014 Published on November 27, 2014

Wintac Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 27, 2014, have decided to hive-off Trade Marks and Marketing Division for the marketing of the Oncology Products in order to have complete focus on the core activity of Product Development and Manufacturing activity for the Regulated Export markets. The size of the Oncology Division business was small and during the previous financial year (2013-14) recorded a sales of Rs. 201 lakhs and contributes about 6.48% to the sales turnover of the Company.

The valuation of the Oncology Division was done on by an Independent Valuer and as per the Valuation Report the valuation was arrived at Rs. 100.53 lakhs. The business is being sold to Bangalore Pharmaceuticals & Research Laboratory Pvt. Ltd., a related party as per the provisions of the Companies Act, 2013. The transaction is on Arms Length Basis and the sale consideration is Rs. 109 lakhs which is more than the valuation of the Independent Valuer.

Source : BSE - www.bseindia.com

Published on November 27, 2014

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.